Witorb Pharma Private Limited

Pharmaceutical company that manufactures and trades various healthcare and dietary supplement products.

2016 | Ahmedabad, Gujarat (India) | Inactive
Last Updated: April 19, 2024

Witorb Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 2 Months
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth %
  • Profit Growth -1552.99%
  • Net Worth -149.50%
  • Total Assets 1140.79%

About Witorb Pharma

Witorb Pharma Private Limited (WPPL) is Strike Off company established on 09 Dec 2016 with its office registered at Ahmedabad, Gujarat, India and has been running since 8 Year, 2 Months with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 19 Apr 2024.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999GJ2016PTC094645

  • Company No.

    094645

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Dec 2016

  • Date of AGM

    29 Sep 2018

  • Date of Balance Sheet

    31 Mar 2018

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Witorb Pharma?

Board Members (2)

Name Designation Appointment Date Status
Chetnaben Dholariya Country flag representing In Director 09-Dec-2016 Current
Saurin Shah Country flag representing In Director 09-Dec-2016 Current

Financial Performance of Witorb Pharma.

Witorb Pharma Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1552.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 149.5%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
1140.79%
Profit or Loss
-1552.99%
Net Worth
-149.50%
EBITDA

What is the Ownership and Shareholding Structure of Witorb Pharma?

In 2018, Witorb Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Witorb Pharma?

Unlock and access historical data on people associated with Witorb Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Witorb Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Witorb Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Witorb Pharma

Recent activity within the organization

  • Annual General Meeting

    Witorb Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.

    29 Sep 2018

  • Balance Sheet

    Witorb Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ahmedabad.

    31 Mar 2018

  • Director Appointment

    Chetnaben Manish Dholariya was appointed as a Director was appointed as a Director on 09 Dec 2016 & has been associated with this company since 8 years 2 months .

    09 Dec 2016

  • Director Appointment

    Saurin Vidhyutkumar Shah was appointed as a Director was appointed as a Director on 09 Dec 2016 & has been associated with this company since 8 years 2 months .

    09 Dec 2016

  • Company Incorporation

    Witorb Pharma Private Limited was registered on 09 Dec 2016 with Roc Ahmedabad & aged 8 years 2 months as per MCA records.

    09 Dec 2016

Frequently asked questions

  • Witorb Pharma Private Limited was incorporated on 09 Dec 2016.

  • The authorized share capital of Witorb Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Witorb Pharma Private Limited.

    • Chetnaben Manish Dholariya
    • Saurin Vidhyutkumar Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of Witorb Pharma Private Limited is 8/A Nilay Apartment Behind Navrang School, Naranpura, Ahmedabad, Gujarat, India, 380009.

  • The corporate identification number (CIN) of Witorb Pharma Private Limited is U74999GJ2016PTC094645 and the company number is 094645 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2018 indicates that The net worth of Witorb Pharma Private Limited has experienced an downturn of -149.50%.

  • The most recent Balance Sheet for Witorb Pharma Private Limited was filed with the ROC on 31 Mar 2018.

People also Viewed

Similar Companies Based on Drug Formulation & Development